An integration analysis of mRNAs and miRNAs microarray data to identify key regulators for ovarian endometriosis based on competing endogenous RNAs
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study integrates mRNA and miRNA microarray data to identify key regulators of ovarian endometriosis based on competing endogenous RNA mechanisms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study aimed to uncover effects of non-coding RNA transcripts on ovarian endometriosis (OEM) development. Two transcription datasets (GSE105764 and GSE105765) about OME were downloaded from Gene Expression Omnibus (GEO) database and the differentially expressed mRNAs, lncRNAs and miRNAs (DEmRNAs, DElncRNAs and DEmiRNAs) between OEM cases and controls were identified followed by protein-protein interaction analysis. Then, co-expression analysis was conducted and DEmiRNAs-DEmRNAs as well as DElncRNAs-DEmiRNAs pairs were predicted to construct the ceRNA network followed by sub-ceRNA network associated with OEM extraction. Functional analyses of DEmRNAs in ceRNA and sub-module network and the survival analysis were also performed to evaluate the correlation of key regulators and OV outcomes. Totally, 1910 DEmRNAs, 158 DElncRNAs and 118 DEmiRNAs were screened between OEM cases and controls and the functional analyses of DEmRNAs showed that they were significantly enriched in cell adhesion. Furthermore, there were 505 nodes in PPI network and ceRNA network included 762 interaction pairs among 357 DEmRNAs, 28 DElncRNAs and 24 DEmiRNAs. The KEGG analysis suggested several genes including FOXO1, STAT5A and RUNX1 were predominately associated with pathways in cancer while IL15 was primarily enriched in cytokine-cytokine receptor interaction pathway. Importantly, these two pathways were also found to be implicated with OEM development. Finally, survival analysis implied that overexpression of ZFPM2-AS1 had a good clinical outcome while the under-expression levels of FOXO1, JUP, STAT5A, RUNX1 and PRKG1-AS1 exhibited a better prognosis for OV. FOXO1, STAT5A, RUNX1 and IL15, PRKG1-AS1 and ZFPM2-AS1 were promising diagnostic makers for OME.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Aberrant expression of CHL1 gene and long non-coding RNA CHL1-AS1, CHL1-AS2 in ovarian endometriosis via openalex
- Activated AKT Pathway Promotes Establishment of Endometriosis via openalex
- Endometriosis and Infertility via openalex
- Identification of Circular RNAs as a Novel Biomarker for Ovarian Endometriosis via openalex
- Increased Activation of the PI3K/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis via openalex
- Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis via openalex
- The Relationship of Circular RNAs With Ovarian Endometriosis via openalex
- W2103152808 via openalex
- W2117977572 via openalex
- W2120983951 via openalex
- W2133465414 via openalex
- W2134555649 via openalex
- W2146512944 via openalex
- W1563658944 via openalex
- W2154362705 via openalex
- W2158217645 via openalex
- W2159675211 via openalex
- W2223740898 via openalex
- W2473193283 via openalex
- W2537623931 via openalex
- W2594468461 via openalex
- W2806502219 via openalex
- W2915769855 via openalex
- W2916047525 via openalex
- W2146616472 via openalex
- W1971554980 via openalex
- W2006556963 via openalex
- W2037027640 via openalex
- W2061119679 via openalex
- W2063959833 via openalex
- W2093589805 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-09-10T06:15:44.054944+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:47.975235+00:00
- unpaywall
- last seen: 2026-09-10T06:36:06.991349+00:00
License: CC0
· commercial use OK